CBD News Round-Up: Australia Proposes OTC Pathway, First EU Novel Food Validation, COVID Boost For UK Firm
Executive Summary
Australia looks at switching CBD as an OTC medicine, CBDepot becomes the first European firm with an EU Novel Food validation and the UK's Vitality CBD gets a boost from the global, coronavirus-driven wellness trend.
You may also be interested in...
Australia Continues Down OTC Path For CBD, But Will It Widen Access?
[Link Fixed] Australia's Ministry of Health has provisionally switched CBD from prescription-only to OTC status to widen access in the absence of any safety concerns and to encourage companies to undertake much-needed clinical trials to prove efficacy for CBD in low doses. However, switch expert Natalie Gauld thinks these expensive trials, and therefore approved Australian OTC CBD products, may not be forthcoming.
CBD Self-Regulation? UK Trade Association Launches Three-Tier Certification System
HBW Insight speaks to the founder of the UK's Association for the Cannabinoid Industry, Steve Moore, about the organization's new three-tier certification system for CBD products marketed in the country, designed to mirror the EU Novel Foods approval process as well as recent local regulatory changes.
US Firm Mile High Files CBD Novel Food Applications In EU
Colorado's Mile High Labs has filed novel food applications with both EFSA and the UK's FSA to ensure it can keep legally supplying its hemp-derived CBD to European customers.